-transparent.png){kind=logo}
To ascertain the topical effectiveness of clotrimazole in oral candidiasis, a troche form was administered to 12 patients suffering from longstanding infection. One-half of the patients took one 10 mg troche and the other half of the patients one 50 mg troche, ten times a day. The troches were not chewed, but were retained in the mouth until completely dissolved. The impressive clinical and mycological response to this treatment as well as the lack of toxicity strongly indicate that further trials are warranted.
Related Publications
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
February 1984,
Archives of internal medicine,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
March 1988,
JAMA,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
November 1978,
The New England journal of medicine,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
March 2015,
Clinical oral investigations,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
January 1997,
Clinical therapeutics,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
November 1990,
Antimicrobial agents and chemotherapy,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
November 1987,
JAMA,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
February 2010,
British journal of clinical pharmacology,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
December 1993,
Journal of acquired immune deficiency syndromes,
L F Montes, and
T G Soto, and
J M Parker, and
G N Ramer
November 1981,
The American journal of medicine,
